SCHEMBL14746153

SCHEMBL14746153

CN(C)n1c2c(cc(C(=O)O)c1=O)CCCc1ccccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
ATM Q13315 1/20 0.38
MAPT P10636 3/20 0.37
RAB9A P51151 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
SRD5A1 P18405 1/20 0.37
SRD5A2 P31213 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MTNR1A P48039 2/20 0.36
MTNR1B P49286 2/20 0.36
NOTUM Q6P988 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
NPC1 O15118 2/20 0.35
RXRA P19793 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14745874 0.97 ALDH1A1 (0.37) CYP2A6MAOAMAOBKMT2AMEN1
SCHEMBL14745760 0.75 ALDH1A1 (0.37) CYP2A6MAOAMAOBSMN1; SMN2TDP1
SCHEMBL2736592 0.71 CNR2 (0.47) TDP1L3MBTL1ALDH1A1
Trimethylammonium SCHEMBL27854577 0.66 ALDH1A1 (0.48) KMT2AMEN1ATMMAPTRAB9A
SCHEMBL17780936 0.65 KMT2A (0.52) KMT2AMEN1MAPTSMN1; SMN2NOTUM
SCHEMBL11007908 0.65 HSP90AA1 (0.51) CYP2A6MAOAMAOBKMT2AMEN1
SCHEMBL9334779 0.64 TSHR (0.40) KMT2AMAPTRAB9ASMN1; SMN2SRD5A1
SCHEMBL26088272 0.64 CNR2 (0.44) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL27590115 0.63 CYP2A6 (0.54) CYP2A6MAOAMAOBKMT2AMEN1
Trimethylammonium SCHEMBL27879967 0.63 MAOA (0.84) CYP2A6MAOAMAOBMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2750678-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC Therapeutics, Inc. (US) 2014-07-09 EP disclosed
WO-2013033228-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2013-03-07 WO disclosed